However, since the deletion of Atgl had a deleterious effect on heart function and currently available inhibitors against ATGL are not effective in humans (Trites and Clugston 2019), targeting directly ATGL for treatment of obesity and diabetes is difficult. Here, PNPLA2 is linked to diabetes mellitus.